Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
GH Analyst Ratings
Strong Buy
19 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GH Stock 12 Month Forecast
Average Price Target
$132.22
▲(24.29% Upside)
| Highest Price Target$175.00 | Average Price Target$132.22 | Lowest Price Target$110.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Craig-Hallum
$125
Buy
17.50%
Upside
Assigned
02/20/26
Wells Fargo
$120→$125
Buy
17.50%
Upside
Reiterated
02/20/26
TD Cowen
$130→$135
Buy
26.90%
Upside
Reiterated
02/20/26
UBS
$175
Buy
64.50%
Upside
Reiterated
02/20/26
William Blair
Buy
―
Reiterated
02/20/26
Piper Sandler
$120
Buy
12.80%
Upside
Reiterated
02/20/26
Mizuho Securities
$135
Buy
26.90%
Upside
Reiterated
02/20/26
Citi
$135→$150
Buy
41.00%
Upside
Reiterated
02/20/26
Evercore ISI
$105→$110
Hold
3.40%
Upside
Reiterated
02/20/26
Canaccord Genuity
$125→$135
Buy
26.90%
Upside
Reiterated
02/20/26
Stifel Nicolaus
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
Barclays
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
J.P. Morgan
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
BTIG
$140→$145
Buy
36.30%
Upside
Reiterated
02/20/26
Robert W. Baird
$120
Buy
12.80%
Upside
Initiated
02/17/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Craig-Hallum
$125
Buy
17.50%
Upside
Assigned
02/20/26
Wells Fargo
$120→$125
Buy
17.50%
Upside
Reiterated
02/20/26
TD Cowen
$130→$135
Buy
26.90%
Upside
Reiterated
02/20/26
UBS
$175
Buy
64.50%
Upside
Reiterated
02/20/26
William Blair
Buy
―
Reiterated
02/20/26
Piper Sandler
$120
Buy
12.80%
Upside
Reiterated
02/20/26
Mizuho Securities
$135
Buy
26.90%
Upside
Reiterated
02/20/26
Citi
$135→$150
Buy
41.00%
Upside
Reiterated
02/20/26
Evercore ISI
$105→$110
Hold
3.40%
Upside
Reiterated
02/20/26
Canaccord Genuity
$125→$135
Buy
26.90%
Upside
Reiterated
02/20/26
Stifel Nicolaus
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
Barclays
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
J.P. Morgan
$120→$130
Buy
22.20%
Upside
Reiterated
02/20/26
BTIG
$140→$145
Buy
36.30%
Upside
Reiterated
02/20/26
Robert W. Baird
$120
Buy
12.80%
Upside
Initiated
02/17/26
Best Analysts Covering Guardant Health
3 Months
xxx
Success Rate
10/13 ratings generated profit
Average Return
+43.70%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +43.70% per trade.
1 Year
Success Rate
13/13 ratings generated profit
Average Return
+129.31%
a rating ―
Copying William Bonello's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +129.31% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
Average Return
+204.59%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +204.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GH Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
1
0
1
2
3
Buy
46
44
33
27
38
Hold
0
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
47
44
34
30
43
Each month's total comprises the sum of three months' worth of ratings.
GH Financial Forecast
GH Stock Forecast FAQ
What is GH’s average 12-month price target, according to analysts?
Based on analyst ratings, Guardant Health’s 12-month average price target is 132.22.
What is GH’s upside potential, based on the analysts’ average price target?
Guardant Health has 24.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GH a Buy, Sell or Hold?
Guardant Health has a consensus rating of Strong Buy which is based on 19 buy ratings, 1 hold ratings and 0 sell ratings.
What is Guardant Health’s price target?
The average price target for Guardant Health is 132.22. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $175.00 ,the lowest forecast is $110.00. The average price target represents 24.29% Increase from the current price of $106.38.
The highest analyst price target is $175.00 ,the lowest forecast is $110.00. The average price target represents 24.29% Increase from the current price of $106.38.
What do analysts say about Guardant Health?
Guardant Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of GH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.